NYU Langone — New York, New York

Public research footprint of NYU Langone, compiled from the ClinicalTrials.gov public registry.

2,036

Registered studies

974

Active

516

Recruiting now

745

Completed

271

Stopped or withdrawn

Most-studied conditions

Anatomic Stage III Breast Cancer AJCC v8 · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Resectable Pancreatic Acinar Cell Carcinoma · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma

Recently updated registry entries

NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at NYU Langone?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.